AU2015216909B2 - Microbiological process - Google Patents

Microbiological process Download PDF

Info

Publication number
AU2015216909B2
AU2015216909B2 AU2015216909A AU2015216909A AU2015216909B2 AU 2015216909 B2 AU2015216909 B2 AU 2015216909B2 AU 2015216909 A AU2015216909 A AU 2015216909A AU 2015216909 A AU2015216909 A AU 2015216909A AU 2015216909 B2 AU2015216909 B2 AU 2015216909B2
Authority
AU
Australia
Prior art keywords
migalastat
seed
fermentation
medium comprises
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2015216909A
Other languages
English (en)
Other versions
AU2015216909A1 (en
Inventor
Emilio ALVAREZ-RUIZ
Andrew John Collis
Alison Sarah DANN
Andrew Peter Fosberry
Sarah Jane READY
Maria Jesus VAZQUEZ MUNIZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Intellectual Property Development Ltd
Original Assignee
GlaxoSmithKline Intellectual Property Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Intellectual Property Development Ltd filed Critical GlaxoSmithKline Intellectual Property Development Ltd
Publication of AU2015216909A1 publication Critical patent/AU2015216909A1/en
Application granted granted Critical
Publication of AU2015216909B2 publication Critical patent/AU2015216909B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/40—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving amylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022—Alpha-galactosidase (3.2.1.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2015216909A 2014-02-17 2015-02-17 Microbiological process Ceased AU2015216909B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14382054 2014-02-17
EP14382054.6 2014-02-17
PCT/EP2015/053282 WO2015121488A1 (en) 2014-02-17 2015-02-17 Microbiological process

Publications (2)

Publication Number Publication Date
AU2015216909A1 AU2015216909A1 (en) 2016-09-01
AU2015216909B2 true AU2015216909B2 (en) 2017-07-20

Family

ID=50150672

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015216909A Ceased AU2015216909B2 (en) 2014-02-17 2015-02-17 Microbiological process

Country Status (9)

Country Link
US (2) US10077458B2 (https=)
EP (1) EP3108002A1 (https=)
JP (1) JP2017506520A (https=)
KR (1) KR20160122206A (https=)
CN (1) CN106687596A (https=)
AU (1) AU2015216909B2 (https=)
CA (1) CA2939698A1 (https=)
RU (1) RU2016137120A (https=)
WO (1) WO2015121488A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150239584A1 (en) * 2014-02-26 2015-08-27 Elc Management Llc Aerosol Package With Fermentation Propulsion
CN106148216B (zh) 2015-03-27 2019-06-04 浙江海正药业股份有限公司 一种链霉菌及其生产米尔贝霉素a3的方法
EP3365458A1 (en) * 2015-10-21 2018-08-29 Novozymes A/S Direct inoculation
WO2022132992A1 (en) * 2020-12-16 2022-06-23 Amicus Therapeutics, Inc. Highly purified batches of pharmaceutical grade 1-deoxygalactonojirimycin compounds
US11623916B2 (en) 2020-12-16 2023-04-11 Amicus Therapeutics, Inc. Highly purified batches of pharmaceutical grade migalastat and methods of producing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774090A (en) * 1980-10-27 1982-05-10 Shionogi & Co Ltd Novel beta-galactosidase inhibitor, gt-2558, its derivative, and production
JPS61280472A (ja) * 1985-06-05 1986-12-11 Shionogi & Co Ltd β−ガラクトシダ−ゼ阻害物質ガラクトスタチン類およびその製造方法
SI2027137T1 (sl) * 2005-06-08 2015-06-30 Amicus Therapeutics, Inc. Čiščenje imino in amino sladkorja
JP2007055961A (ja) * 2005-08-26 2007-03-08 Mercian Corp １−デオキシガラクトノジリマイシンの製造方法、合成中間体およびその製造方法
SG10201604757RA (en) * 2011-03-11 2016-08-30 Amicus Therapeutics Inc Dosing regimens for the treatment of fabry disease
JP5904522B2 (ja) * 2011-03-17 2016-04-13 国立大学法人東北大学 アザ糖を生産する微生物
US20120283290A1 (en) * 2011-05-06 2012-11-08 Amicus Therapeutics Inc. Quantitation of gl3 in urine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MIYAKE ET AL: "The structures of a ß-galactosidase inhibitor, galactostatin, and its derivatives". Agricultural and Biological Chemistry, 1988, vol. 52, pages 661-666 *

Also Published As

Publication number Publication date
AU2015216909A1 (en) 2016-09-01
CA2939698A1 (en) 2015-08-20
JP2017506520A (ja) 2017-03-09
EP3108002A1 (en) 2016-12-28
RU2016137120A (ru) 2018-03-22
US20180208955A1 (en) 2018-07-26
KR20160122206A (ko) 2016-10-21
WO2015121488A1 (en) 2015-08-20
US20160355856A1 (en) 2016-12-08
CN106687596A (zh) 2017-05-17
US10077458B2 (en) 2018-09-18

Similar Documents

Publication Publication Date Title
AU2015216909B2 (en) Microbiological process
CN105647997A (zh) 肌肉肌醇和肌肉肌醇衍生物的制造方法
CN108026546A (zh) 微杆菌属菌株用于生产抗菌剂的用途
US9382562B2 (en) Strains of Serratia plymuthica producing turanose and uses thereof
US6558931B1 (en) Process for the preparation of Fexofenadine
JPH0689012B2 (ja) Ｃｌ‐１５７７‐ｂ▲下４▼化合物およびその製法
CN119193738A (zh) 一种用于提高纳他霉素产量及纯度的发酵方法
KR20140007425A (ko) 일종의 사이클릭 리포펩티드 화합물의 제조방법
NO152451B (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
JP2873894B2 (ja) 環状デプシペプチドおよびその製造法
CN113396214A (zh) 从链霉菌属sp.mcc-0151生产尼日利亚菌素的方法
US5306496A (en) Antibiotics NK374186A, NK374186B, NK374186B3 and NK374186C3, process for producing the same, and use of the same
EP0233740B1 (en) Aerocavin and aerocyanidin - antibiotics
KR910000454B1 (ko) 스트렙토마이세스의 변이주 kccb₂및 이를 이용한 항생물질의 제조방법
KR900005531B1 (ko) 지베렐라 푸지쿠로이 hb 901 및 이를 이용한 지베렐린의 제조방법
HU194314B (en) Process for preparing new, alpha-glucosidase inhibiting pseudooligosaccharides
JPH0578322A (ja) 新規抗生物質ｓｆ２７３８物質及びその製造法並びに制癌剤
SU697056A3 (ru) Способ получени антибиотического комплекса лизолипина
JP2748273B2 (ja) 新規抗生物質ｐｆ１０１５物質ならびにその製造法
JPH0321158B2 (https=)
BRPI0117138B1 (pt) Processo para a produção de sal de sódio de pravastatina usando-se um microorganismo streptomyces flavidovirens dsm 14455”
GB2093017A (en) Polyene antibiotics
NO301488B1 (no) Polyhydroksycyklopentanderivat, fremgangsmåte til fremstilling derav, samt biologisk rene stammer av mikroorganismer som er anvendelige i fremgangsmåten
JPS62277378A (ja) カズサマイシンｂ、その製造法およびその用途
JPS6244915B2 (https=)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired